Asep Medical Holdings Inc
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnosti… Read more
Market Cap & Net Worth: Asep Medical Holdings Inc (SEPSF)
Asep Medical Holdings Inc (PINK:SEPSF) has a market capitalization of $430.49K ($430.49K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38174 globally and #12423 in its home market, demonstrating a -35.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Asep Medical Holdings Inc's stock price $0.04 by its total outstanding shares 11123729 (11.12 Million).
Asep Medical Holdings Inc Market Cap History: 2022 to 2025
Asep Medical Holdings Inc's market capitalization history from 2022 to 2025. Data shows change from $4.45 Million to $430.49K (-46.44% CAGR).
Asep Medical Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Asep Medical Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
92.98x
Asep Medical Holdings Inc's market cap is 92.98 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $1.97 Million | $21.14K | -$8.23 Million | 92.98x | N/A |
Competitor Companies of SEPSF by Market Capitalization
Companies near Asep Medical Holdings Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Asep Medical Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Asep Medical Holdings Inc Historical Marketcap From 2022 to 2025
Between 2022 and today, Asep Medical Holdings Inc's market cap moved from $4.45 Million to $ 430.49K, with a yearly change of -46.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $430.49K | -3.25% |
| 2024 | $444.95K | -77.36% |
| 2023 | $1.97 Million | -55.83% |
| 2022 | $4.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Asep Medical Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $430.49K USD |
| MoneyControl | $430.49K USD |
| MarketWatch | $430.49K USD |
| marketcap.company | $430.49K USD |
| Reuters | $430.49K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.